TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 113626

Group type: COMPARATOR
Intervention: Primary radiation treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Primary surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Successful radiation for early glottic larynx lesions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Radiation or surgery for supraglottic larynx lesions
Number of subjects: 100
Study: 30789432

Group type: EXPERIMENTAL
Intervention: Optimal treatment selection rule based on predicted mean difference in outcomes comparing those with versus without treatment, conditional on covariates.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment selection when resources are constrained.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment selection when resources are not constrained.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment selection in the presence of side effects and costs.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment selection to maximize effect heterogeneity.
Number of subjects: 0
Study: 28388820

Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate, sulfasalazine, and hydroxychloroquine)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Methotrexate-etanercept
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Triple therapy and Methotrexate-etanercept
Number of subjects: 353
Study: 26640058

Group type: EXPERIMENTAL
Intervention: CVVH-HCO
Number of subjects: 0

Group type: COMPARATOR
Intervention: CVVH-std
Number of subjects: 0
Study: 23592679

Group type: EXPERIMENTAL
Intervention: High energy density (HED) breakfast consumed quickly (FR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low energy density (LED) breakfast consumed slowly (SR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High energy density (HED) breakfast consumed slowly (SR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low energy density (LED) breakfast consumed quickly (FR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Eating rate (ER) manipulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Energy density (ED) manipulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Active or total ghrelin AUC
Number of subjects: 20
Study: 21291517

Group type: EXPERIMENTAL
Intervention: CRASH-1 trial
Number of subjects: 30019

Group type: COMPARATOR
Intervention: CRASH-2 trial
Number of subjects: 30019
Study: 19879683

Group type: EXPERIMENTAL
Intervention: E2/DRSP (17beta‐estradiol 1mg plus drospirenone 2 mg daily)
Number of subjects: 59

Group type: COMPARATOR
Intervention: E2/NETA (17beta‐estradiol 1mg plus norethisterone acetate 0.5 mg daily)
Number of subjects: 59
Study: 17144496

Group type: EXPERIMENTAL
Intervention: Rhino Rapid Nasal Dressing with Gel Knit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vaseline gauze
Number of subjects: 0
Study: 14716694

Group type: EXPERIMENTAL
Intervention: donepezil+sertraline (50-200 mg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: donepezil+sertraline
Number of subjects: 144

Group type: COMPARATOR
Intervention: donepezil+placebo
Number of subjects: 144
Study: 11387489

Group type: EXPERIMENTAL
Intervention: Power transcranial color duplex sonography (power TCDS)
Number of subjects: 171
Study: 9759799

Group type: EXPERIMENTAL
Intervention: Theophylline (target STC of 10 to 15 mg/L)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8169705

Group type: EXPERIMENTAL
Intervention: Methohexital
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40
Study: 3348159

Group type: EXPERIMENTAL
Intervention: 50 micrograms phylloquinone/d for 12 d
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 500 micrograms phylloquinone/d for 12 d
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vitamin K restriction
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50 micrograms phylloquinone/d and 500 micrograms phylloquinone/d
Number of subjects: 10
Study: 30148973

Group type: EXPERIMENTAL
Intervention: Endurance training (3 sets of 10 min with 80%-90% of maximum heart rate)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Resistance training (4 sets of 8 repetitions with 80% of 1-repetition maximum)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Concurrent training (combination of endurance and resistance training)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 29124831

Group type: EXPERIMENTAL
Intervention: Topical triamcinolone acetonide 0.1% oral paste
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oral methotrexate
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of topical triamcinolone acetonide 0.1% and oral methotrexate
Number of subjects: 45
Study: 27895475

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 21
Study: 25044085

Group type: EXPERIMENTAL
Intervention: Enclomiphene citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical testosterone gel (1% T gel)
Number of subjects: 0
Study: 23170814

Group type: EXPERIMENTAL
Intervention: TOC communication tool
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Traditional dictated summary
Number of subjects: 1400
Study: 20864808

Group type: EXPERIMENTAL
Intervention: Active vaccine (DNA prime, recombinant fowlpox virus boost)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 17363185

Group type: EXPERIMENTAL
Intervention: Hydrogel (Intrasite)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Dry dressings (Tricotex)
Number of subjects: 357
Study: 15080407

Group type: EXPERIMENTAL
Intervention: Deferiprone 50 mg/kg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Deferiprone 75 mg/kg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no chelator)
Number of subjects: 75
Study: 11085324

Group type: EXPERIMENTAL
Intervention: MDMA (50 to 150 mg)
Number of subjects: 0
Study: 9193364

Group type: EXPERIMENTAL
Intervention: MOPP/ABV hybrid regimen
Number of subjects: 301

Group type: COMPARATOR
Intervention: Alternating MOPP/ABVD
Number of subjects: 301
Study: 8173687

Group type: EXPERIMENTAL
Intervention: Felodipine-Metoprolol 10/100 mg
Number of subjects: 159

Group type: COMPARATOR
Intervention: Felodipine 10 mg
Number of subjects: 159

Group type: COMPARATOR
Intervention: Metoprolol 100 mg
Number of subjects: 159
Study: 3781686

Group type: EXPERIMENTAL
Intervention: Cholestyramine (16 g/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Probucol (1 g/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Probucol + Cholestyramine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Probucol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination therapy (Probucol + Cholestyramine)
Number of subjects: 12
Study: 3235476

Group type: EXPERIMENTAL
Intervention: Flosequinan (single dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flosequinan (chronic treatment)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine (steady state)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 12
Study: 31288849

Group type: EXPERIMENTAL
Intervention: Neuromuscular training exercise (muscle strength training, balance training, knee joint proprioception training)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Taping (using 'Y' and 'I' type taping)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Health education (education lectures once a week for three months)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Neuromuscular training exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Taping
Number of subjects: 60

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 60
Study: 28362054

Group type: EXPERIMENTAL
Intervention: 0.1% cyclosporine A cationic emulsion (CsA CE)
Number of subjects: 489
Study: 25445400

Group type: EXPERIMENTAL
Intervention: simeprevir plus peginterferon/ribavirin (PR)
Number of subjects: 2007
Study: 23374200

Group type: EXPERIMENTAL
Intervention: Cranial electric stimulation (active device) for 60 minutes for five days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham device (placebo control) for 60 minutes for five days
Number of subjects: 0
Study: 21641516

Group type: EXPERIMENTAL
Intervention: Yogic practices (35-40 min/day, five days a week for six months)
Number of subjects: 170
Study: 18033724

Group type: EXPERIMENTAL
Intervention: Active Music Engagement (AME)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Music Listening (ML)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Audio Storybooks (ASB)
Number of subjects: 83
Study: 16813785

Group type: EXPERIMENTAL
Intervention: Clinic environment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Suburban street environment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Shopping mall environment
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: No task
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Motor task
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cognitive task
Number of subjects: 27
Study: 15545155

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS
Number of subjects: 1498

Group type: COMPARATOR
Intervention: Co‐amilozide (diuretic combination)
Number of subjects: 1498
Study: 11554954

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 660

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg and 400 mg
Number of subjects: 660
Study: 10740725

Group type: EXPERIMENTAL
Intervention: Y virilin (Treatment Group A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (Treatment Group B)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Y virilin (for azospermic patients)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (for azospermic patients)
Number of subjects: 52
Study: 8296075

Group type: EXPERIMENTAL
Intervention: MNSs system segregation distortions among mothers
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Ss heterozygotes
Number of subjects: 400

Group type: COMPARATOR
Intervention: Subsamples from different hospitals
Number of subjects: 400
Study: 3726800

Group type: EXPERIMENTAL
Intervention: PROPLEX
Number of subjects: 0

Group type: COMPARATOR
Intervention: PROPLEX SX
Number of subjects: 0
Study: 29559834

Group type: COMPARATOR
Intervention: Oral Ibuprofen (OI) for 6 weeks
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Median Nerve Neural Mobilization (MNNM)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cervical Lateral Glide (CLG)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: All interventions (MNNM, CLG, OI)
Number of subjects: 105
Study: 27081873

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) [λ=640 nm, SAEF=1.06 J/cm²]
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Light-Emitting Diode (LED) [λ=660±20 nm, SAEF=0.24 J/cm²]
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 25623934

Group type: EXPERIMENTAL
Intervention: Morphine 1mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tramadol 50mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5% Ringer's lactate 1ml (Control)
Number of subjects: 30
Study: 22935323

Group type: EXPERIMENTAL
Intervention: LAM-EC group (received counseling for both LAM and EC with in-advance provision of one packet of EC pills)
Number of subjects: 1158

Group type: COMPARATOR
Intervention: LAM-only group (received proper LAM counseling without EC counseling)
Number of subjects: 1158

Group type: COMPARATOR
Intervention: LAM-only group
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: LAM-EC group
Number of subjects: 1158
Study: 20939928

Group type: EXPERIMENTAL
Intervention: Patient navigation and activation intervention
Number of subjects: 344

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study: 18172020

Group type: EXPERIMENTAL
Intervention: Citalopram (Level 1)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Switch to sustained-release bupropion (Level 2)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Switch to sertraline (Level 2)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Switch to extended-release venlafaxine (Level 2)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Continue citalopram and receive augmentation with sustained-release bupropion (Level 2)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Continue citalopram and receive augmentation with buspirone (Level 2)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Anxious depression group (Level 1 and Level 2)
Number of subjects: 2876
Study: 17010756

Group type: EXPERIMENTAL
Intervention: 16-week cyclosporin A (CsA)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 8-week cyclosporin A (CsA) + 8-week placebo
Number of subjects: 99

Group type: COMPARATOR
Intervention: 16-week placebo
Number of subjects: 99
Study: 14689413

Group type: EXPERIMENTAL
Intervention: Double-lumen endotracheal tube
Number of subjects: 32

Group type: COMPARATOR
Intervention: Single-lumen tube with bronchial blocker
Number of subjects: 32
Study: 10983674

Group type: EXPERIMENTAL
Intervention: High-dose GIK therapy (insulin solution 225 IU, glucose, potassium, and mixed amino acids 11.4 g)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (mixed amino acids 11.4 g)
Number of subjects: 33
Study: 8959306

Group type: EXPERIMENTAL
Intervention: Telethermography (TTG) scans
Number of subjects: 14
Study: 1543675

Group type: EXPERIMENTAL
Intervention: 1% terbinafine cream
Number of subjects: 33

Group type: COMPARATOR
Intervention: 0.1% gentamicin sulphate cream
Number of subjects: 33
Study: 4024909

Group type: EXPERIMENTAL
Intervention: TTS‐scopolamine (one patch)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TTS‐scopolamine (two patches)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (100 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31881049

Group type: EXPERIMENTAL
Intervention: Secondary schooling
Number of subjects: 49
Study: 29808331

Group type: EXPERIMENTAL
Intervention: Topical chamomile oleogel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 26848258

Group type: EXPERIMENTAL
Intervention: 20 mg/day conivaptan
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: 40 mg/day conivaptan
Number of subjects: 251
Study: 25340768

Group type: EXPERIMENTAL
Intervention: Healthy Nordic diet (ND) rich in whole grain rye and wheat, berries, fruits and vegetables, rapeseed oil, three fish meals per week, and low-fat dairy products for 18/24 weeks.
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control diet for 18/24 weeks.
Number of subjects: 158
Study: 22788574

Group type: EXPERIMENTAL
Intervention: Moleca® shoes for six months for at least six hours daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no use of Moleca® shoes)
Number of subjects: 56
Study: 19280085

Group type: EXPERIMENTAL
Intervention: Impella LP2.5 percutaneous left ventricular support
Number of subjects: 6

Group type: COMPARATOR
Intervention: No support (control group)
Number of subjects: 6
Study: 17297176

Group type: EXPERIMENTAL
Intervention: EMLA‐C
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control (placebo cream)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: EMLA‐C (1-2 hours application)
Number of subjects: 400
Study: 14985870

Group type: EXPERIMENTAL
Intervention: Bone scintigraphy evaluated by the new method of determining total or partial involvement of individual vertebrae
Number of subjects: 84

Group type: COMPARATOR
Intervention: Bone scintigraphy evaluated by the conventional Soloway grading
Number of subjects: 84
Study: 11600329

Group type: EXPERIMENTAL
Intervention: RAMP waveform (ramp onset and ramp offset)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ramp-to-Parabola (R-P) waveform (ramp onset with parabolic offset)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SINE waveform (sine-wave onset with sine wave offset)
Number of subjects: 8
Study: 9673473

Group type: EXPERIMENTAL
Intervention: 0.5% apraclonidine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 0.25% apraclonidine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Artificial tears (control group)
Number of subjects: 54
Study: 7526468

Group type: EXPERIMENTAL
Intervention: Vinorelbine (Navelbine) as a single agent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine in combination with cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine in combination with other agents (5-fluorouracil/leucovorin, mitomycin-C, ifosfamide, carboplatin, paclitaxel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine and cisplatin followed by accelerated radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine in small cell lung cancer
Number of subjects: 0
Study: 2657057

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 29676193

Group type: EXPERIMENTAL
Intervention: Fidget spinners (used by 48 children during the initial phase of treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fidget spinners (used by 48 children during both phases of treatment)
Number of subjects: 60
Study: 31278097

Group type: EXPERIMENTAL
Intervention: 80 ppm nitric oxide (NO) gas
Number of subjects: 250

Group type: COMPARATOR
Intervention: 80 ppm nitrogen (N2) gas (control group)
Number of subjects: 250
Study: 28872486

Group type: EXPERIMENTAL
Intervention: Divalent iron (ferrous sulfate) 2 mg/kg/d for 5 months
Number of subjects: 112

Group type: COMPARATOR
Intervention: Trivalent iron (ferric polymaltose) 2 mg/kg/d for 5 months
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both groups (Divalent and Trivalent)
Number of subjects: 112
Study: 27271310

Group type: EXPERIMENTAL
Intervention: Midodrine (2.5-10 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Binder (servo-controlled venous compression at 40 mmHg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Binder
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of midodrine and binder
Number of subjects: 19
Study: 24638033

Group type: EXPERIMENTAL
Intervention: Reading in color with specially prepared books pairing letters with colors; details on dosage and duration not specified.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reading experience questionnaire administered post-intervention; details on dosage and duration not specified.
Number of subjects: 0
Study: 22479155

Group type: EXPERIMENTAL
Intervention: SP-AQ (sulfadoxine-pyrimethamine plus amodiaquine)
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: SP-AS (sulfadoxine-pyrimethamine plus artesunate)
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1121
Study: 20807303

Group type: EXPERIMENTAL
Intervention: Decaffeinated green tea (960 mL daily for 6 months)
Number of subjects: 54
Study: 17618081

Group type: EXPERIMENTAL
Intervention: 200 Gauss magnets
Number of subjects: 40

Group type: COMPARATOR
Intervention: 50 Gauss magnets
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 40
Study: 15883143

Group type: EXPERIMENTAL
Intervention: Collaborative care as part of the Multifaceted Oncology Depression Program
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 55
Study: 11887555

Group type: EXPERIMENTAL
Intervention: Invasive strategy (early angioplasty with coronary stents)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative strategy (medical stabilization)
Number of subjects: 0
Study: 9817151

Group type: EXPERIMENTAL
Intervention: Single-breath (SB) method
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tidal-breathing (TB) method
Number of subjects: 80
Study: 9726343

Group type: EXPERIMENTAL
Intervention: Albendazole (15 mg/kg/day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 63
Study: 1765727

Group type: EXPERIMENTAL
Intervention: Multilevel study guides with different levels of referential cues, implemented through teacher‐directed, dyadic, and independent instructional groups.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Single‐level study guides without referential cues, implemented as an independent activity.
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Multilevel study guides in high school social studies.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Single‐level study guides in high school social studies.
Number of subjects: 82
Study: 7123469

Group type: EXPERIMENTAL
Intervention: Low lint, nonwoven surgical sponge material
Number of subjects: 232

Group type: COMPARATOR
Intervention: Cotton gauze
Number of subjects: 232
Study: 30328059

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sporanox
Number of subjects: 0
Study: 27481208

Group type: EXPERIMENTAL
Intervention: real iTBS
Number of subjects: 17

Group type: COMPARATOR
Intervention: sham iTBS
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: iTBS
Number of subjects: 17
Study: 24842156

Group type: EXPERIMENTAL
Intervention: HPV and cytology double testing (intervention arm)
Number of subjects: 12527

Group type: COMPARATOR
Intervention: Cytology with samples frozen for future HPV testing (control arm)
Number of subjects: 12527

Group type: EXPERIMENTAL
Intervention: HPV positivity
Number of subjects: 12527

Group type: EXPERIMENTAL
Intervention: Type 16 HPV
Number of subjects: 12527

Group type: EXPERIMENTAL
Intervention: Type 31 HPV
Number of subjects: 12527
Study: 26880056

Group type: EXPERIMENTAL
Intervention: Carotid stenting
Number of subjects: 1710

Group type: COMPARATOR
Intervention: Endarterectomy
Number of subjects: 1710
Study: 24034580

Group type: EXPERIMENTAL
Intervention: Buccal placement of 400-mcg misoprostol
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73